EcoDrugPlus

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion A

Ensembl ID : ENSCHAG00000005189
Gene Symbol: FAUA
1 Cross references
300 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase A

Ensembl ID : ENSCHAG00000021975
Gene Symbol: FYNA
1 Cross references
192 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase B

Ensembl ID : ENSCHAG00000016571
Gene Symbol: FYNB
1 Cross references
201 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSCHAG00000004744
Gene Symbol: GPR119
1 Cross references
175 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSCHAG00000004876
Gene Symbol: GPR119
1 Cross references
175 Possible Orthologues:

Gtpase Kras

Ensembl ID : ENSCHAG00000015882
Gene Symbol: LOC105900436
3 Cross references
203 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSCHAG00000026993
Gene Symbol: HCK
3 Cross references
203 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSCHAG00000023648
Gene Symbol: ITK
3 Cross references
208 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1a

Ensembl ID : ENSCHAG00000015360
Gene Symbol: IMPDH1A
1 Cross references
259 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1b

Ensembl ID : ENSCHAG00000021027
Gene Symbol: IMPDH1B
1 Cross references
258 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 2

Ensembl ID : ENSCHAG00000015599
Gene Symbol: IMPDH2
1 Cross references
202 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSCHAG00000003626
Gene Symbol: JAK1
3 Cross references
167 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).